Industries > Pharma > Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026

North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing

PUBLISHED: 27 September 2016
PAGES: 317
PRODUCT CODE: PHA0145
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0145 Categories: ,

In its updated report, Visiongain provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market.

This report also analyses leading companies in pharmaceutical contract manufacturing. The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6bn in 2015, having grown by more than 6% from 2014.

The new study predicts strong growth in that industry’s revenue, reaching $84.0bn worldwide in 2020, with further expansion expected.

Our 317-page report provides 185 tables, 110 figures and analysis of 30 leading companies.

The content of each profile differs, depending on the organisation. In general, though, a profile gives you the following information:
• Overview of the company’s contract manufacturing services and operations
• Analysis of recent financial performance – annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2015 onwards
Forecasting of pharmaceutical manufacturing revenue to 2026, as well as projected operating profit and margin for some companies.

Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026

Leading Pharmaceutical Contract Manufacturing Organisations profiled in this report:
• Catalent
• Patheon
• Baxter
• AbbVie
• Pfizer
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Aenova
• Famar
• Vetter
• Almac
• Delpharm
• Siegfried
• Corden
• Recipharm
• Aesica
• Nipro
• Daito
• Teva API
• Esteve Quimica
• Euticals
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy’s Laboratories

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOs) 2016-2026


Latest Pharma news

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Visiongain Publishes Artificial Intelligence (AI) in Drug Discovery Market Report 2021-2031

Factors such as increasing data volumes for analysis, quick turnaround time for the discovery and development new drug, computing power, AI also helps in targeted manufacturing and others drive the market growth.

01 April 2021

READ

Visiongain Publishes Inhalation & Nasal Spray Generic Drugs Market Report 2021-2031

Rising prevalence of chronic respiratory diseases including asthma, COPD, and allergic rhinitis; rising geriatric population, escalating investment in drug R&D by biopharmaceutical & pharmaceutical companies; growing respiratory health care awareness; and new product launches worldwide are some of the major factors that boosting the growth of global inhalation & nasal spray generic drugs market.

31 March 2021

READ

Categories